CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC)

CUSIP: N2451R105

Q1 2021 13F Holders as of 31 Mar 2021

Security identity
Shares outstanding
22,421,536
Holder snapshot
Share change
+3,673,062
Put/Call ratio
129%
Reported price per share
$91.46
Number of holders
83
Value change
+$337,575,946
Number of buys
61
Number of sells
18

Security key

N2451R105

Report period

Q1 2021

Institutions

83

Top holders

10

Ownership snapshot

Top shareholders of CVAC - CureVac N.V. - Common Shares, par value (euro)0.12 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
83
Shares
14,053,252
Rows loaded
83
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
58
Q1 2021 holders
83
Holder diff
25
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .